Company intelligence / Profile preview

CNSystems Medizintechnik GmbH

Ownership: Private
Development stage: Commercial

Overview

The company’s non-invasive hemodynamic monitoring technologies are clinically validated with over a thousand peer-reviewed publications. Their products are used globally by more than six thousand customers for continuous blood pressure and advanced cardiovascular diagnostics. The solutions have been proven effective in both clinical practice and research settings. No drug or therapeutic clinical trials; the company focuses on medical devices.

Therapeutic areas: OtherCardiovascularNeurology
Modalities: Device (non-invasive hemodynamic monitoring)Diagnostic device
Industry: Physiological Monitoring

Partnerships

Dräger (integration of TMSmart Pod for patient monitoring)various global partners integrating OEM modules into their own systems

Beyond the preview

Go deeper on CNSystems Medizintechnik GmbH.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CNSystems Medizintechnik GmbH.

Explore the full profile